Joshua Hexter sold $611K of ORMP stock

Joshua Hexter, COO & Cbo of Oramed Pharmaceuticals Inc. (ORMP), sold 137,000 shares of ORMP stock worth $611K, per an SEC Form 4 filed Jul 2, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Jul 1, 2026, 1 day before it was made public.

ORMP has moved -16.3% since the trade date, from $4.61 to $3.86 (Nov 6, 2026 close).